Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Chinese patent medicine for treating gout

A concentration and compound preparation technology, which is applied in the direction of drug combination, pharmaceutical formula, organic active ingredients, etc., can solve the problems of high toxicity and side effects, difficult to cure gout disease, and easy repeated exacerbation of gout

Inactive Publication Date: 2015-01-28
SHANGHAI PUDONG GAOXING BIOTECH RES INST
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The current marketed drugs for the treatment of gout are difficult to cure gout symptoms. They treat the symptoms but not the root cause, and have relatively large toxic and side effects. Once the drug is stopped, gout is likely to recur and aggravate the attack

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0013] The present invention uses 200 cases, each oral tablet or pill 0.5-1.0g, three times a day, swallowed with warm boiled water after meals, for 2-3 weeks, has a good curative effect on gout symptoms, after a week, the blood The uric acid concentration was controlled within the normal range, and no toxic side effects occurred in any case. After taking the medicine, there has been no rebound phenomenon of uric acid concentration in the blood, ranging from half a year to more than a year.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a Chinese patent medicine for treating gout. The compound preparation capable of reducing concentration of serum uric acid and treating gout is characterized by being prepared from the following components in percentage by weight: 30 percent of rhizoma smilacis glabrae, 15 percent of yam rhizome, 10 percent of benzbromarone, 10 percent of eleutheroside, 5 percent of picroside, 10 percent of triptolide, 10 percent of croceic acid and 10 percent of cordycepic acid, and the eight medicinal materials are mixed according to the proportion to prepare a tablet. The tablet or pill is orally taken for 0.5-1.0g each time, and is taken three times a day with warm boiled water after meals, and is taken continuously for 2-3 weeks.

Description

technical field [0001] The present invention relates to a compound oral tablet, more specifically a compound preparation capable of reducing blood uric acid concentration and treating gout. Background technique [0002] Gout is a common chronic disease. The current commercially available medicines for the treatment of gout are difficult to radically cure gout symptoms. They treat the symptoms but not the root cause, and have relatively large toxic and side effects. Once the medicine is stopped, the gout is likely to aggravate repeatedly. Contents of the invention [0003] The technical problem to be solved by the present invention is to overcome the deficiencies in the prior art and provide a safe, effective and oral medicine with little toxic and side effects. [0004] The present invention adopts Smilax tuckahoe (its English name is Glabrous Greenbrier Rhizome, Rhizome of Glabrous Greenbrier) as the basis, and is equipped with 萆薢 (its English name is Castor seed), benzb...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/90A61K36/896A61P19/06A61K31/585A61K31/194A61K31/7048A61K31/343A61K31/047
CPCA61K36/90A61K31/047A61K31/194A61K31/343A61K31/585A61K31/7048A61K36/8945A61K36/896
Inventor 胡宝山陆培群
Owner SHANGHAI PUDONG GAOXING BIOTECH RES INST
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products